Skip to content
Recall Observatory FDA recall evidence

Drug product

Dymista (azelastine hydrochloride and fluticasone propionate) Nasal Spray, 137 mcg/50 mcg per spray, 120 Metered Sprays, 23 g net fill weight bottle, Rx Only, Manufactured by: Cipla Ltd., Goa, India, M.L. No. 546; For: Meda Pharmaceuticals Inc., Somerset, New Jersey 08873-4120, NDC 0037-0245-23.

D-0424-2019

February 01, 2019

Class II

Product summary

Firm
Mylan Pharmaceuticals Inc.
Event
Event 81980
Status
Terminated
Classification
Class II
Quantity
10,390 bottles
Official record key
drug-enforcement:D-0424-2019

Official wording

Reason: Defective Container: Potential for broken glass in the neck area of the glass bottles.

Code information: Lot: GA70535, Exp. April 2019

Distribution pattern: Nationwide in the USA.

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    Defective Container: Potential for broken glass in the neck area of the glass bottles.